Stockreport

Janux dives as gaps in prostate cancer study data worry investors [Yahoo! Finance Canada]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF The lead ?candidate, JANX007, is being developed to treat metastatic castration-resistant prostate cancer, a form that ?progresses despite the standard approach of main [Read more]